Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORAL Start: Tofacitinib vs Methotrexate in RA
NCT01039688Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jan 2010
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 30
01
Overview
Phase 3, randomised, double-blind trial of tofacitinib oral solution in rheumatoid arthritis (RA) (3 arms), sponsored by Pfizer. Primary endpoints: Modified Total Sharp Score at 6 months, American College of Rheumatology 70 Response at 6 months and 2 more. Started Jan 2010; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01039688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01039688.